Brii Biosciences Ltd. buy nvestor
Start price
08.01.22
/
50%
€3.10
Target price
08.01.23
€6.00
Performance (%)
-31.61%
End price
22.01.22
€2.12
Summary
This prediction ended on 22.01.22 with a price of €2.12. Massive losses of -31.61% were the result for the BUY prediction by nvestor. nvestor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Brii Biosciences Ltd. | 5.833% | 5.833% | -72.979% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to nvestor what are the pros and cons of Brii Biosciences Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Revenue growth >5% per year expected
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Cons
Comments by nvestor for this prediction
In the thread Brii Biosciences Ltd. diskutieren
In the thread Trading Brii Biosciences Ltd.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by nvestor for Brii Biosciences Ltd.
Brii Biosciences Ltd.
Start price
Target price
Perf. (%)
€1.63
05.02.22
05.02.22
€3.00
05.02.23
05.02.23
-7.98%
19.02.22
19.02.22
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
